EHL Bio Co., Ltd.
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis (NCT07377838) | EHL Bio Co., Ltd. | 2026-06-01 |
| Safety and Efficacy of KDSTEM Inj. in Patients With Chronic Kidney Disease (NCT06071143) | EHL Bio Co., Ltd. | 2024-02-29 |
| Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis (NCT04137562) | EHL Bio Co., Ltd. | 2019-12-11 |
| Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis (NCT03252340) | EHL Bio Co., Ltd. | 2017-09-19 |
Track EHL Bio Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.